Recombinant human glucagon - Adocia

Drug Profile

Recombinant human glucagon - Adocia

Alternative Names: BC Glucagon; Biochaperone® human glucagon

Latest Information Update: 24 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Adocia
  • Class Antihypoglycaemics; Pancreatic hormones
  • Mechanism of Action Glucagon receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase I Hypoglycaemia

Most Recent Events

  • 20 Nov 2017 Efficacy and adverse events data from a phase I trial in Hypoglycaemia released by Adocia
  • 22 Jun 2017 Recombinant human glucagon - Adocia is available for licensing as of 22 Jun 2017.
  • 01 Jun 2017 Phase-I clinical trials in Hypoglycaemia in Germany (SC) (NCT03176524)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top